SINOVAC BIOTECH LTD's ticker is SVA and the CUSIP is P8696W104. A total of 29 filers reported holding SINOVAC BIOTECH LTD in Q2 2021. The put-call ratio across all filers is - and the average weighting 3.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $340,000,000 | 0.0% | 2,718,735 | 0.0% | 7.22% | +17.2% |
Q2 2023 | $340,000,000 | 0.0% | 2,718,735 | 0.0% | 6.16% | -7.7% |
Q1 2023 | $340,000,000 | 0.0% | 2,718,735 | 0.0% | 6.67% | +2.6% |
Q4 2022 | $340,000,000 | -0.1% | 2,718,735 | 0.0% | 6.50% | +2.9% |
Q3 2022 | $340,500,000 | -2.6% | 2,718,735 | 0.0% | 6.32% | -0.2% |
Q2 2022 | $349,500,000 | +380.7% | 2,718,735 | -4.3% | 6.33% | +577.3% |
Q4 2021 | $72,700,000 | -7.3% | 2,839,500 | 0.0% | 0.94% | +8.5% |
Q3 2021 | $78,400,000 | +2.1% | 2,839,500 | 0.0% | 0.86% | +10.9% |
Q2 2021 | $76,800,000 | +6.7% | 2,839,500 | 0.0% | 0.78% | +15.5% |
Q1 2021 | $72,000,000 | 0.0% | 2,839,500 | 0.0% | 0.67% | +6.8% |
Q4 2020 | $72,000,000 | +163.7% | 2,839,500 | 0.0% | 0.63% | +83.7% |
Q3 2020 | $27,300,000 | +7.1% | 2,839,500 | 0.0% | 0.34% | -4.5% |
Q2 2020 | $25,500,000 | +48.7% | 2,839,500 | 0.0% | 0.36% | +24.7% |
Q1 2020 | $17,151,000 | 0.0% | 2,839,500 | 0.0% | 0.29% | +17.6% |
Q4 2019 | $17,151,000 | +3.3% | 2,839,500 | 0.0% | 0.24% | -22.2% |
Q3 2019 | $16,611,000 | 0.0% | 2,839,500 | 0.0% | 0.32% | +22.6% |
Q2 2019 | $16,611,000 | -9.6% | 2,839,500 | 0.0% | 0.26% | -9.5% |
Q1 2019 | $18,372,000 | -6.8% | 2,839,500 | 0.0% | 0.28% | -22.0% |
Q4 2018 | $19,706,000 | -8.9% | 2,839,500 | 0.0% | 0.36% | +39.5% |
Q3 2018 | $21,637,000 | +2.1% | 2,839,500 | 0.0% | 0.26% | +3.2% |
Q2 2018 | $21,183,000 | -13.4% | 2,839,500 | 0.0% | 0.25% | -16.5% |
Q1 2018 | $24,448,000 | +9.3% | 2,839,500 | 0.0% | 0.30% | +7.1% |
Q4 2017 | $22,375,000 | +19.0% | 2,839,500 | +6.4% | 0.28% | +57.2% |
Q3 2017 | $18,806,000 | +4.4% | 2,667,500 | 0.0% | 0.18% | -4.8% |
Q2 2017 | $18,006,000 | +17.8% | 2,667,500 | 0.0% | 0.19% | +9.2% |
Q1 2017 | $15,285,000 | -2.9% | 2,667,500 | 0.0% | 0.17% | -13.9% |
Q4 2016 | $15,738,000 | 0.0% | 2,667,500 | 0.0% | 0.20% | +12.3% |
Q3 2016 | $15,738,000 | -0.5% | 2,667,500 | 0.0% | 0.18% | +8.5% |
Q2 2016 | $15,818,000 | -7.2% | 2,667,500 | 0.0% | 0.16% | -7.8% |
Q1 2016 | $17,045,000 | +11.7% | 2,667,500 | 0.0% | 0.18% | +29.7% |
Q4 2015 | $15,258,000 | +12.6% | 2,667,500 | 0.0% | 0.14% | +0.7% |
Q3 2015 | $13,551,000 | -3.2% | 2,667,500 | 0.0% | 0.14% | +33.0% |
Q2 2015 | $14,004,000 | +5.8% | 2,667,500 | 0.0% | 0.10% | -8.8% |
Q1 2015 | $13,231,000 | -10.3% | 2,667,500 | -5.5% | 0.11% | -19.9% |
Q4 2014 | $14,756,000 | +8.7% | 2,821,500 | 0.0% | 0.14% | -0.7% |
Q3 2014 | $13,571,000 | +46.9% | 2,821,500 | +72.3% | 0.14% | +31.5% |
Q2 2014 | $9,236,000 | -21.7% | 1,637,500 | 0.0% | 0.11% | -25.5% |
Q1 2014 | $11,790,000 | +17.6% | 1,637,500 | 0.0% | 0.14% | -1.4% |
Q4 2013 | $10,022,000 | -11.1% | 1,637,500 | -13.1% | 0.15% | -26.9% |
Q3 2013 | $11,268,000 | +52.2% | 1,884,200 | 0.0% | 0.20% | +28.0% |
Q2 2013 | $7,405,000 | – | 1,884,200 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Orbimed Advisors | 2,718,735 | $340,500,000 | 6.32% |
Vivo Capital, LLC | 5,900,000 | $38,173,000 | 4.21% |
Neumann Advisory Hong Kong Ltd | 315,586 | $2,042 | 0.72% |
Yorktown Management & Research Co Inc | 74,893 | $485,000 | 0.63% |
Skandinaviska Enskilda Banken AB (publ) | 40,000 | $259,000 | 0.00% |
Renaissance Technologies | 2,375,841 | $1,537,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 1,687 | $11,000 | 0.00% |
NORTHERN TRUST CORP | 13,787 | $55,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GROUP ONE TRADING, L.P. | 412 | $27,000 | 0.00% |